EMCDDA Home
  • EN
Search

Table TDI-107. All clients entering outpatient treatment by primary drug and age at first use, 2011 or most recent year available

Part (vii) All cannabis outpatient clients by country and age at first use

Country<1515-1920-2425-2930-3435-3940-4445+Age knownAge not knownTotal
Belgium76109135211220911861395
Bulgaria4940200019423
Czech Republic163209194121039940439
Denmark10548368116851320043222326
Germany630877996041654825161314978476419742
Estonia19711:::::::
Ireland63545633130111130341164
Greece18539841710006326638
Spain134694803599158833322579224198611210
France72185592865183652719::2792:
Italy2112735601609160192543225675911987957
Cyprus552621021030204342436
Latvia344103196310017656232
Lithuania:::::::::::
Luxembourg4::::::::::
Hungary4221665435148511887275402754
Malta45664111:::4:
Netherlands1267135116448341192288627475633
Austria2184744212123475621777
Poland4368231:::::4:
Portugal517529342820005205525
Romania832205100066066
Slovenia13255::1:::::
Slovakia3710214310001570157
Finland208370100011131142
Sweden4335352983001100901009
United Kingdom613865601266223713284302821050211023160
Croatia141503437320::198:
Turkey:::::::::::
Norway141810100135540
Total370553538454611194642267145144653081751579825
 

Notes:

: Indicates no data are available

(1) Data are from 2010.

(2) In 2011 around 27% of all clients and 32% of new clients were registered as not known / missing for the primary drug category. Caution should be made when comparing data over time.

(3) In 2010 Latvia submitted a new dataset with a more precise TDI EMCDDA definition. Caution should be made when comparing data with previous years.

(4) Data are from 2010. Data presented in the table come from TDI pilot project. Caution should be made when interpreting the data.

(5) In 2010 came into implementation a new national information system implying methodological changes particularly in the registration criteria. Caution should be made when comparing 2010 data with previous years.

(6) Data are from 1st of April 2010 to 31st March 2011.

For more information relative to the treatment centre type, please see Table TDI-7.

See also Table TDI-11 part(i), part(ii)

‘General notes for interpreting data'’ on the Explanatory notes and help page.

Source:

Reitox national reports 2012- Table TDI Outpatient Treatment Centres

About the EMCDDA

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the reference point on drugs and drug addiction information in Europe. Inaugurated in Lisbon in 1995, it is one of the EU's decentralised agencies. Read more >>

Contact us

EMCDDA
Praça Europa 1, Cais do Sodré
1249-289 Lisbon
Portugal
Tel. (351) 211 21 02 00
Fax (351) 218 13 17 11

More contact options >>

Page last updated: Friday, 26 April 2013